New guidelines for the management of adult lower respiratory tract infections

European Respiratory Journal

Volumn 38, Issue 6, 2011, Pages 1250-1251

  Woodhead, M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONSULTATION; DISEASE EXACERBATION; DISEASE SEVERITY; EDITORIAL; GENERAL PRACTICE; HEALTH CARE PRACTICE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MEDICAL SOCIETY; METHODOLOGY; PATIENT CARE; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ADULT; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; PRACTICE GUIDELINES AS TOPIC; RESPIRATORY TRACT INFECTIONS; TREATMENT OUTCOME;

EID: 82555194473     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00105211     Document Type: Editorial

References (15)

1. ERS Task Force Report. Guidelines for management of adult community-acquired lower respiratory tract infections. Eur Respir J 1998; 11: 986-991.
2. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005; 26: 1138-1180. (Pubitemid 41829947)
3. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of lower respiratory tract infections. Clin Microbiol Infect 2011; 17: Suppl. 6, 1-24.
4. Butler CC, Hood K, Verheij T, et al. Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries. BMJ 2009; 338: b2242.
5. WHO. The Global Burden of Disease: 2004 Update. Geneva, World Health Organization, 2008.
6. Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 2010; [Epub ahead of print DOI: 10.1136/thx.2009.129502].
7. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363: 1128-1138.
8. Goossens H, Ferech M, Vander SR, et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365: 579-587. (Pubitemid 40247914)
9. Capelastegui A, Espana PP, Quintana JM, et al. Management of community-acquired pneumonia and secular trends at different hospitals. Respir Med 2005; 99: 268-278. (Pubitemid 40267942)
10. Kohlhammer Y, Raspe H, Marre R, et al. Antibiotic treatment of community acquired pneumonia varies widely across Germany. J Infect 2007; 54: 446-453. (Pubitemid 46584426)
11. Dambrava PG, Torres A, Vallès X, et al. Adherence to guidelines'empirical antibiotic recommendations and community-acquired pneumonia outcome. Eur Respir J 2008; 32: 892-901.
12. Blasi F, Iori I, Bulfoni A, et al. Can CAP guideline adherence improve patient outcome in internal medicine departments? Eur Respir J 2008; 32: 902-910.
13. Paul MF, Nielsen AD, Gafter-Gvili A, et al. The need for macrolides in hospitalised community-acquired pneumonia: propensity analysis. Eur Respir J 2007; 30: 525-531. (Pubitemid 351182077)
14. Wood J, Butler CC, Hood K, et al. Antibiotic prescribing for adults with acute cough/lower respiratory tract infection: congruence with guidelines. Eur Respir J 2011; 38: 112-118.
15. Khan AR, Khan S, Zimmerman V, et al. Quality and strength of evidence of the Infectious Diseases Society of America clinical practice guidelines. Clin Infect Dis 2010; 51: 1147-1156.